These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34182038)

  • 1. An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research.
    Yang P; Yang Y; Wu Y; Huang C; Ding Y; Wang X; Wang S
    J Virol Methods; 2021 Sep; 295():114221. PubMed ID: 34182038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.
    Zhao G; Du L; Ma C; Li Y; Li L; Poon VK; Wang L; Yu F; Zheng BJ; Jiang S; Zhou Y
    Virol J; 2013 Aug; 10():266. PubMed ID: 23978242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.
    Chen Z; Cui Q; Ran Y; Achi JG; Chen Z; Rong L; Du R
    J Virol; 2024 Jul; 98(7):e0050424. PubMed ID: 38899934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An easy method for developing fusion enabled SARS-CoV2 virus fusion mimic (SCFM), bypassing the need of Bio Safety Level (BSL) facility.
    Das A; Dutta S; Sharma D; Pal A; Ganguli N; Majumdar SS
    Bioengineered; 2021 Dec; 12(1):4407-4419. PubMed ID: 34436976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudovirus-Based Assays for the Measurement of Antibody-Mediated Neutralization of SARS-CoV-2.
    Balinsky C; Jani V; Sun P; Williams M; Defang G; Porter KR
    Methods Mol Biol; 2022; 2452():361-378. PubMed ID: 35554917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern
    Chiem K; Morales Vasquez D; Silvas JA; Park JG; Piepenbrink MS; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Walter MR; de la Torre JC; Kobie JK; Ye C; Martinez-Sobrido L
    J Virol; 2021 Oct; 95(22):e0112621. PubMed ID: 34495697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter.
    Tsai WY; Ching LL; Hsieh SC; Melish ME; Nerurkar VR; Wang WK
    Emerg Microbes Infect; 2021 Dec; 10(1):894-904. PubMed ID: 33929934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Lentiviral Pseudotype System to Characterize SARS-CoV-2 Glycoprotein.
    Mi D; Hu J; Qian Z
    Methods Mol Biol; 2023; 2610():187-199. PubMed ID: 36534292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring Neutralizing Antibodies to SARS-CoV-2 Using Lentiviral Spike-Pseudoviruses.
    Neerukonda SN; Vassell R; Weiss CD; Wang W
    Methods Mol Biol; 2022; 2452():305-314. PubMed ID: 35554914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2.
    Neerukonda SN; Vassell R; Herrup R; Liu S; Wang T; Takeda K; Yang Y; Lin TL; Wang W; Weiss CD
    PLoS One; 2021; 16(3):e0248348. PubMed ID: 33690649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-Fluorescence Labeling Pseudovirus for Real-Time Imaging of Single SARS-CoV-2 Entry in Respiratory Epithelial Cells.
    Ma Y; Mao G; Wu G; Chen M; Qin F; Zheng L; Zhang XE
    ACS Appl Mater Interfaces; 2021 Jun; 13(21):24477-24486. PubMed ID: 33961399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repositioning of histamine H
    Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
    Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept.
    Cruz-Cardenas JA; Gutierrez M; López-Arredondo A; Castañeda-Delgado JE; Rojas-Martinez A; Nakamura Y; Enciso-Moreno JA; Palomares LA; Brunck MEG
    Sci Rep; 2022 Oct; 12(1):17966. PubMed ID: 36289285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.
    Hu J; Gao Q; He C; Huang A; Tang N; Wang K
    Genes Dis; 2020 Dec; 7(4):551-557. PubMed ID: 32837985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles.
    Plescia CB; David EA; Patra D; Sengupta R; Amiar S; Su Y; Stahelin RV
    J Biol Chem; 2021; 296():100103. PubMed ID: 33214224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants.
    Wang HI; Chuang ZS; Kao YT; Lin YL; Liang JJ; Liao CC; Liao CL; Lai MMC; Yu CY
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
    Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
    J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants.
    Sun H; Xu J; Zhang G; Han J; Hao M; Chen Z; Fang T; Chi X; Yu C
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.